Harnessing host–virus evolution in antiviral therapy and immunotherapy
Abstract Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy. The high error rate of RNA synthesis and reverse‐transcription confers genome plasticity, enabling the remarkable adaptability of RNA viruses to antiviral intervention. However, this p...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2019-01-01
|
| Series: | Clinical & Translational Immunology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/cti2.1067 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|